Supernus Pharmaceuticals (SUPN) Gross Margin (QoQ) (2013 - 2025)

Supernus Pharmaceuticals (SUPN) Gross Margin (QoQ) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Supernus Pharmaceuticals 2.72 Bn 2.34 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -100.00
Sep 30, 2025 30.00
Jun 30, 2025 35.00
Mar 31, 2025 446.00
Dec 31, 2024 -498.00
Sep 30, 2024 64.00
Jun 30, 2024 71.00
Mar 31, 2024 59.00
Dec 31, 2023 79.00
Sep 30, 2023 282.00
Jun 30, 2023 -30.00
Mar 31, 2023 -154.00
Dec 31, 2022 87.00
Sep 30, 2022 -256.00
Jun 30, 2022 -27.00
Mar 31, 2022 -107.00
Dec 31, 2021 150.00
Sep 30, 2021 553.00
Jun 30, 2021 -629.00
Mar 31, 2021 149.00